Brian O'Flynn, PhD

See how drug activity, not drug synergy should guide preclinical drug combination discovery such as for leukemia including antagonistic drug combos

See how an artificial intelligence single-cell microfluidics pharmacotyping tool helps identify drugs for T-cell acute lymphoblastic leukemia

See how a patient-derived xenograft library is shaping Wilms tumor treatments.

See how clinicians are working to bring the best SMA treatment to more patients.

Learn how discoveries in brain development are shaping brighter futures.

See how tools like mitoedit and NETBID reveal mitochondrial DNA (mtDNA) ties to diseases such as acute lymphoblastic leukemia

Watch how St. Jude visual storytellers use artistry to support scientific discovery

Explore the ingenuity behind therapeutic optimization

Neurosurgeon Paul Klimo, MD, explains posterior fossa syndrome, and how surgeons can work to reduce its risk.

See how combining sequencing approaches provides a ‘one-stop shop’ for diagnosing AML.